Riskpilot← Back to searchSign inGet full accessEquity Science AB
ABActiveOrg 5567831283Österrikevägen 5 GladeholmRental and operating of own or leased real estate · NACE 6820Est. 20090 employees
Revenue 2024
SEK 131K
+552% vs 2023
EBITDA margin
262.6%
+57% vs 2023
Equity ratio
31.2%
Financial strength
Net profit 2024
SEK -58K
+74% vs 2023
| Revenue | SEK 131K | +552% |
| EBITDA | SEK 344K | +57% |
| Net profit | SEK -58K | +74% |
| Total assets | SEK 9M | +4% |
| Equity | SEK 2,8M | -2% |
| Employees | 0 | — |
Legal name
Equity Science AB
Org number
5567831283
Legal form
Aktiebolag
NACE code
6820 · Rental and operating of own or leased real estate
Founded
28 maj 2009
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolagets verksamhet ska vara att renovera och hyra ut kulturhus i hotelliknande verksamhet, äga och driva kursgård samt gårdsbutik. Aktiebolaget ska även äga och bedriva jordbruk, konsultverksamhet inom programmering samt direkt eller indirekt bedriva handel för egen räkning med finansiella intrument, dock ej sådan handel som är tillståndspliktig enligt lagen (2007:528) om värdepappersmarknaden samt därmed förenlig verksamhet.
Address
Österrikevägen 5 Gladeholm
Email
johan.nygren@equityscience.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 256 | 254 | 102 | 20 | 131 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 1 013 | 304 | 259 | 220 | 344 |
| Depreciation & amort. | −192 | −216 | −237 | −249 | −288 |
| EBIT | 821 | 88 | 22 | −29 | 56 |
| Net financials | −101 | −96 | −148 | −194 | −115 |
| Profit before tax | 583 | −8 | 32 | −223 | −58 |
| Tax | −89 | −0 | −7 | — | −0 |
| Net profit | 494 | −8 | 25 | −223 | −58 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 8 815 | 8 759 | 8 836 | 8 670 | 9 027 |
| Equity | 3 382 | 3 074 | 3 099 | 2 876 | 2 817 |
| Long-term debt | 5 106 | 5 358 | 5 671 | 5 651 | 5 554 |
| Short-term debt | 189 | 190 | 65 | 143 | 656 |
| Total debt | 5 295 | 5 548 | 5 736 | 5 794 | 6 210 |
EBITDA margin
262.6%
This company
15.8%
Market median
+1562% vs market
20202024
Equity ratio
31.2%
This company
38.2%
Market median
+18% vs market
20202024
Return on equity
-2.1%
This company
18.4%
Market median
-111% vs market
20202024
Net profit margin
-44.3%
This company
8.1%
Market median
-647% vs market
20202024
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
20202024
Debt / equity
2.20×
This company
0.62×
Market median
-255% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Equity Science AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karl Johan Nygren | Board of Directors | 0 companies |
| Per Erik Ingemar Loheden | Deputy Board Member | 0 companies |